Legal Representation
Attorney
Ronald M. Kachmarik
USPTO Deadlines
Next Deadline
2040 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250902)
Due Date
September 02, 2031
Grace Period Ends
March 02, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 2, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Sep 2, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 2, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 15, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 15, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 9, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 21, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jun 19, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jun 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 9, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 9, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 20, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| May 20, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 25, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 17, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 14, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 14, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 13, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Scientific research for medical purposes in the field of pharmaceuticals; pharmaceutical research and development services; Scientific research in the nature of conducting clinical trials to determine the efficacy and safety of pharmaceutical products in the treatment of decompensated liver disease, acute-on-chronic liver failure (ACLF); conducting scientific feasibility studies, including analysis; providing information, including results and data, relating to scientific or medical research in the field of pharmaceuticals and development of pharmaceutical products, especially from an online searchable database; Scientific research in the nature of conducting clinical trials for others; pharmaceutical and biological development and research services for third parties; clinical research in the field of hepatic, metabolic, gastrointestinal and oncological diseases and disorders; evaluation of the efficacy of pharmaceutical products; Scientific research in the nature of clinical development services.
Class 044
Advisory services relating to health being medical care; medical information; Providing medical information, namely, compilation of medical reports; medical information services provided via the Internet; medical diagnosis services.
Additional Information
Design Mark
The mark consists of the stylized wording "UNVEIL-IT" in teal blue, with a representation of a liver to the left in teal blue, and a check mark replacing the "V" also in teal blue.
Color Claim
The color(s) teal blue is/are claimed as a feature of the mark.
Pseudo Mark
UNVEIL IT
Classification
International Classes
042
044